title: Unsaturated fatty acids induce mesenchymal stem cells to increase secretion of angiogenic mediators.
abstract: Mesenchymal stem cells (MSC) represent emerging cell-based therapies for diabetes and associated complications. Ongoing clinical trials are using exogenous MSC to treat type 1 and 2 diabetes, cardiovascular disease and non-healing wounds due to diabetes. The majority of these trials are aimed at exploiting the ability of these multipotent mesenchymal stromal cells to release soluble mediators that reduce inflammation and promote both angiogenesis and cell survival at sites of tissue damage. Growing evidence suggests that MSC secretion of soluble factors is dependent on tissue microenvironment. Despite the contribution of fatty acids to the metabolic environment of type 2 diabetes, almost nothing is known about their effects on MSC secretion of growth factors and cytokines. In this study, human bone marrow-derived MSC were exposed to linoleic acid, an omega-6 polyunsaturated fatty acid, or oleic acid, a monounsaturated fatty acid, for seven days in the presence of 5.38 mM glucose. Outcomes measured included MSC proliferation, gene expression, protein secretion and chemotaxis. Linoleic and oleic acids inhibited MSC proliferation and altered MSC expression and secretion of known mediators of angiogenesis. Both unsaturated fatty acids induced MSC to increase secretion of interleukin-6, VEGF and nitric oxide. In addition, linoleic acid but not oleic acid induced MSC to increase production of interleukin-8. Collectively these data suggest that exposure to fatty acids may have functional consequences for MSC therapy. Fatty acids may affect MSC engraftment to injured tissue and MSC secretion of cytokines and growth factors that regulate local cellular responses to injury.
authors: Department of Surgery, University of Washington, Seattle, Washington 98104, USA.
authors: Andria N
authors: AN
authors: Smith
authors: Lara A
authors: LA
authors: Muffley
authors: Austin N
authors: AN
authors: Bell
authors: Surawej
authors: S
authors: Numhom
authors: Anne M
authors: AM
authors: Hocking
mesh_terms: D042501:Angiogenic Proteins / Q000235:genetics / Q000378:metabolism*; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism*; D002452:Cell Count; D049109:Cell Proliferation / Q000187:drug effects; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D002633:Chemotaxis / Q000187:drug effects; D015870:Gene Expression / Q000187:drug effects; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D019787:Linoleic Acid / Q000494:pharmacology*; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism; D019301:Oleic Acid / Q000494:pharmacology*; D014945:Wound Healing
chemical_list: D042501:Angiogenic Proteins; D019301:Oleic Acid; D009569:Nitric Oxide; D019787:Linoleic Acid; D005947:Glucose